Home › Viral Infections › California › Los Angeles
Viral Infections clinical trials in Los Angeles, CA
3 studies for Viral Infections are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
RecruitingPhase 2
- LA Universal Research Center, Inc., Los Angeles
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Downtown L.A. Research Center, Inc., Los Angeles
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
RecruitingPhase 1/2Healthy volunteers welcome
- UCLA Westwood, Los Angeles
About Viral Infections
Viruses cause familiar infections such as the common cold, but they also cause severe illnesses. Learn more about viral infections and their symptoms.
More about Viral Infections on MedlinePlus
Viral Infections trials in other cities
- Washington, DC12 studies
- Boston, MA6 studies
- Houston, TX6 studies
- Hialeah, FL5 studies
- Baltimore, MD5 studies
- Atlanta, GA4 studies
- Cincinnati, OH4 studies
- Dallas, TX4 studies
- Columbus, OH4 studies
- Miami, FL3 studies
- Worcester, MA3 studies
- Tampa, FL3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.